Subsequently, we outline the role of the CXCL12-CXCR4/CXCR7 signaling axis in the development of various cancers, including leukemia, breast cancer, lung cancer, prostate cancer and multiple myeloma. This evidence concerns the gene CXCL12 and plasma cell myeloma.